https://www.selleckchem.com/pr....oducts/aminoguanidin
Indeed, many candidate drugs based on heterocyclic skeletons are currently being tested. Among them, quinoline derivatives like gatifloxacin, moxifloxacin and bedaquiline (sirturo), and pyridine molecules such as sudoterb and agent BRD-8000.3 have been shown to have high potential for more effective treatment of the drug-resistant forms of TB disease. In this work we review the most significant advances in the design of such molecules discussing briefly their physicochemical parameters (descriptors) calculated by av